| For: | Li DD, Tang YL, Wang X. Challenges and exploration for immunotherapies targeting cold colorectal cancer. World J Gastrointest Oncol 2023; 15(1): 55-68 [PMID: 36684057 DOI: 10.4251/wjgo.v15.i1.55] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i1/55.htm |
| Number | Citing Articles |
| 1 |
Takehiko Yokobori. Editorial Comment on: The Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery. Annals of Surgical Oncology 2023; 30(11): 6306 doi: 10.1245/s10434-023-13761-4
|
| 2 |
Yuting Li, Lufang Wang. Bidirectional Regulation in the Tumour Microenvironment: The Interaction Between Tumour‐Associated Macrophages and T Cells Reshapes the Paradigm of Cancer Immunotherapy. Immunology 2026; 178(1): 1 doi: 10.1111/imm.70103
|
| 3 |
Shuanglin Tian, Jinrui Liu, Xiulan Yang, Jiawei Guo. The CXCL12-CXCR4 axis in colorectal cancer: immune regulation, metastatic progression, and therapeutic implications. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1783222
|
| 4 |
Viswapriya Viswalingam, Dileep Kumar. Chemoresistance in Glioblastoma. 2026; : 329 doi: 10.1016/B978-0-443-33910-3.00007-8
|
| 5 |
Aitoshi Hoshimoto, Atsushi Tatsuguchi, Ryohei Hamakubo, Takayoshi Nishimoto, Jun Omori, Naohiko Akimoto, Shu Tanaka, Shunji Fujimori, Tsutomu Hatori, Akira Shimizu, Katsuhiko Iwakiri. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World Journal of Gastroenterology 2023; 29(40): 5566-5581 doi: 10.3748/wjg.v29.i40.5566
Abstract(930) |
Core Tip(998) |
Full Article(HTML)(2748)
|
Full Article with Cover (PDF)-4633K(234)
|
Full Article (Word)-1014K(51)
|
Audio-989K(24)
|
Peer-Review Report-253K(183)
|
Answering Reviewers-96K(163)
|
Supplementary Material-53K(169)
|
Full Article (PDF)-4374K(293)
|
Full Article (XML)-200K(198)
|
Times Cited (6)
|
Total Visits (13625)
|
Open
|
| 6 |
Mohammad Reza Keivany, Elham Shojae Asrami, Mohammadreza Besharatloo, Hanieh latifi, Amir Hossein Barjasteh. Advances in immunotherapy for colorectal cancer: overcoming resistance in mismatch repair-proficient tumors. Cancer Cell International 2026; 26(1) doi: 10.1186/s12935-026-04177-7
|
| 7 |
Hailang Jiang, Bingtian Xu. The critical role of epithelial-mesenchymal transition (EMT) in colorectal cancer progression and therapeutic outcomes. Critical Reviews in Oncology/Hematology 2026; 220: 105189 doi: 10.1016/j.critrevonc.2026.105189
|
| 8 |
Qi Wang, Yifeng Chen. Artificial intelligence-enhanced ultrasound multimodal imaging and tissue characterization for predicting immunotherapy efficacy in rectal cancer. Tissue and Cell 2026; 102: 103613 doi: 10.1016/j.tice.2026.103613
|
| 9 |
Gholam‐Reza Khosravi, Samaneh Mostafavi, Sanaz Bastan, Narges Ebrahimi, Roya Safari Gharibvand, Nahid Eskandari. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Communications 2024; 44(5): 521 doi: 10.1002/cac2.12539
|
| 10 |
Edward Zheng, Marcin Włodarczyk, Andrzej Węgiel, Aleksandra Osielczak, Maria Możdżan, Laura Biskup, Agata Grochowska, Maria Wołyniak, Dominik Gajewski, Mateusz Porc, Kasper Maryńczak, Łukasz Dziki. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1398289
|
| 11 |
Yuan Yuan, Ya-Fang Chen, Xiao-Mei Liu, Ying Hu, Shuang Hao, Xin-Yan Dai. Analysis of risk factors and prognostic prediction in advanced colorectal cancer undergoing immunotherapy combined with targeted therapy. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1640469
|
| 12 |
Yanqing Li, Xiaofei Cheng. Enhancing Colorectal Cancer Immunotherapy: The Pivotal Role of Ferroptosis in Modulating the Tumor Microenvironment. International Journal of Molecular Sciences 2024; 25(17): 9141 doi: 10.3390/ijms25179141
|
| 13 |
Ehsan Gharib, Gilles A. Robichaud. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies. International Journal of Molecular Sciences 2024; 25(17): 9463 doi: 10.3390/ijms25179463
|
| 14 |
Wenkai Kang, Zhiqiang Zhang, Wentao Li, Qingyuan Zhang, Ningning Li, Youheng Jiang, Junjing Zhang, Yulong He. Breaching the immune-cold barrier in pMMR/MSS metastatic colorectal cancer: emerging strategies beyond standard care. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1773002
|
| 15 |
Qian Li, Wanyi Luo, Li Xiao, Xin Xu, Xian Peng, Lei Cheng, Xuedong Zhou, Xin Zheng.
Microbial manipulators:
Fusobacterium nucleatum
modulates the tumor immune microenvironment in colorectal cancer
. Journal of Oral Microbiology 2025; 17(1) doi: 10.1080/20002297.2025.2544169
|
| 16 |
Rui-ting Ma, Yuanyuan Wang, Feng Ji, Jian-nan Chen, Tian-jun Wang, Yan Liu, Ming-xing Hou, Zhi-gang Guo. YTHDF1’s grip on CRC vasculature: insights into LINC01106 and miR-449b-5p-VEGFA axis. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03360-y
|
| 17 |
Brindley Hapuarachi, Sarah Danson, Jon Wadsley, Munitta Muthana. Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1335256
|
| 18 |
Mingcong Xu, Guorui Zhang, Ting Cui, Jiaqi Liu, Qiuyu Wang, Desi Shang, Tingting Yu, Bingzhou Guo, Jinjie Huang, Chunquan Li. Cross‐modal integration of bulk RNA‐seq and single‐cell RNA sequencing data to reveal T‐cell exhaustion in colorectal cancer. Journal of Cellular and Molecular Medicine 2024; 28(18) doi: 10.1111/jcmm.70101
|
| 19 |
Kai Ji, Hang Jia, Zixuan Liu, Guanyu Yu, Rongbo Wen, Tianshuai Zhang, Zhiying Peng, Wenjiang Man, Yucheng Tian, Can Wang, Qianlong Ling, Wei Zhang, Leqi Zhou, Mulin Liu, Bing Zhu. New insight in immunotherapy and combine therapy in colorectal cancer. Frontiers in Cell and Developmental Biology 2025; 12 doi: 10.3389/fcell.2024.1453630
|
| 20 |
Jianing Wang, Junbao Xu, Xiaoqing Ma, Qianqian Wang, Zhengchun Liu, Xuecheng Zhang, Yongqiang Wei, Shuai Wang, Chunjing Liang, Peiling Zhai. Epigenetic therapy combined with radiotherapy reshapes tumor immune response. Experimental and Molecular Pathology 2026; 146: 105040 doi: 10.1016/j.yexmp.2026.105040
|
| 21 |
Yu Wang, Maoyan Tang, Cheng Peng, Jiaqi Yang, Fangyuan Liu, Danni Ding, Ying Guo, Yang Yu, Fengjuan Han. VEGF/VEGFR targeting-induced vascular normalization: a key strategy to reverse cold tumor phenotype and potentiate immunotherapy in gynecologic cancers. International Immunopharmacology 2026; 182: 116821 doi: 10.1016/j.intimp.2026.116821
|